Etravirine
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 805 publications
Drug Resistance in HIV Following First-line ART Failure: Insights from a Cross-sectional Study in India.
Journal: The Journal of the Association of Physicians of India
Published: March 12, 2026
Drug resistance characteristics of rilpivirine in HIV-1-infected patients before starting antiretroviral therapy in nine provinces of China
Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
Published: March 01, 2026
Correction: Ly et al. Inhibitory Effect of Etravirine, a Non-Nucleoside Reverse Transcriptase Inhibitor, via Anterior Gradient Protein 2 Homolog Degradation Against Ovarian Cancer Metastasis. Int. J. Mol. Sci. 2022, 23, 944.
Journal: International journal of molecular sciences
Published: January 31, 2026
Cyclization-Inspired Structural Optimization: Designing Potent Non-nucleoside Reverse Transcriptase Inhibitors with Enhanced Safety and Selectivity.
Journal: Journal of medicinal chemistry
Published: January 09, 2026
Prioritization of adverse events related to integrase inhibitors and NNRTIs: a disproportionality analysis using data from the FAERS database.
Journal: The Journal of antimicrobial chemotherapy
Published: August 28, 2025
Virological Failure on Long-Acting Injectable Cabotegravir and Rilpivirine: An Analysis of Subtypes, Drug Levels, Resistance, and Therapeutic Implications.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: August 11, 2025
Simultaneous Quantification of Doravirine, Lamivudine, and Tenofovir Disoproxil Fumarate in Human Plasma by UPLC-MS/MS: Method Development and Validation.
Journal: Turkish journal of pharmaceutical sciences
Published: August 01, 2025
Switching from etravirine to doravirine in virologically suppressed people with HIV: results from the French multicentre SWEED observational study.
Journal: The Journal of antimicrobial chemotherapy
Published: June 22, 2025
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors.
Journal: Journal of visualized experiments : JoVE
Published: May 26, 2025
Exploring Potential for Repurposing Antiretroviral Drugs Etravirine and Efavirenz in Prostate and Bladder Cancer.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 24, 2025
AI-driven discovery of antiretroviral drug bictegravir and etravirine as inhibitors against monkeypox and related poxviruses.
Journal: Communications biology
Published: April 14, 2025
Last Updated: 04/28/2026